Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.21.2
STOCKHOLDERS' EQUITY (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
item
$ / shares
shares
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
$ / shares
shares
Sep. 30, 2020
USD ($)
Dec. 31, 2020
$ / shares
shares
Class of Stock [Line Items]                
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.00001         $ 0.00001   $ 0.00001
Gross Proceeds from Issuance Initial Public Offering   $ 460,989 $ 9,708,038 $ 12,503,750   $ 12,503,750    
Proceeds from sale of common stock and warrants in initial public offering, net [1]           $ 0 $ 11,503,488  
Term of warrants 5 years 5 years 5 years     5 years    
Exercise price of warrants issued | $ / shares $ 5.50 $ 5.50 $ 5.50     $ 5.50    
Proceeds from exercise of stock options           $ 8,361 0  
Number of member of board of directors to whom shares were issued | item     4          
Warrants to purchase shares of common stock | shares   94,286 773,000          
Stock-based compensation expense $ 263,247     (5,465) $ (5,465) 523,999 $ 78,477  
Unrecognized stock-based compensation expense 1,400,000         $ 1,400,000    
Unrecognized stock-based compensation expense, period of recognition           2 years 10 months 24 days    
Common stock aggregate issuance date fair value $ 264,502 $ 27,570 $ 513,103 9,000 $ 3,000      
Number of shares issued under share based compensation plan | shares     70,040          
Warrants exercised | shares   112,647 (2,169,021)     (2,281,668)    
Exercise price of warrants exercised | $ / shares           $ 5.04    
Net cash proceeds from exercise of warrants   $ 428,719 $ 9,274,911          
Issuance costs from exercise of warrants   $ 32,270 $ 433,127 $ 1,898,005   $ 1,000,262    
Common stock issued during the period | shares   108,961 2,047,361          
Common stock, shares issued | shares 14,252,886         14,252,886   11,756,109
2017 Stock Option Plan                
Class of Stock [Line Items]                
Common stock issued upon exercise of options (in shares) | shares 2,815              
Exercise price | $ / shares $ 2.97              
Proceeds from exercise of stock options $ 8,361              
2017 Plan                
Class of Stock [Line Items]                
Common stock aggregate issuance date fair value     $ 560,520          
Number of shares issued under share based compensation plan | shares     30,040          
2017 Plan | Employees                
Class of Stock [Line Items]                
Number of employees in a share based compensation plan   6            
Common stock aggregate issuance date fair value   $ 963,701            
Number of shares issued under share based compensation plan | shares   167,600            
2017 Plan | Employees | Tranche one                
Class of Stock [Line Items]                
Vesting period   1 year            
Common stock aggregate issuance date fair value   $ 957,313            
2017 Plan | Employees | Trance two                
Class of Stock [Line Items]                
Common stock aggregate issuance date fair value   $ 6,388            
Minimum                
Class of Stock [Line Items]                
Exercise price of warrants exercised | $ / shares   $ 4.20 $ 4.20          
Maximum                
Class of Stock [Line Items]                
Exercise price of warrants exercised | $ / shares   $ 6.25 $ 6.25          
[1] Includes gross proceeds of $12,503,750, less underwriting discounts and commissions of $1,000,262.